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ABSTRACT
Purpose: Egypt has the highest prevalence of chronic Hepatitis C virus (HCV) infections
and also a high prevalence of female genital mutilation (FGM). The high prevalence
chronic hepatitis C has been attributed to HCV transmission by contaminated injections
for the control of schistosomiasis. HCV infection has not been well studied in the context
of female genital mutilation (FGM). We sought to identify associations between FGM
and HCV using the Egypt Demographic and Health Survey (EDHS), 2008.
Methods: FGM was chosen as the main independent variable of interest. Other
independent variables such as age, education, marital status, residence, beliefs associated
with FGM, history of blood transfusion, surgery, sharing needles, and history of
schistosomiasis were included in the analysis. Throughout the analysis, HCV infection
was used as the main dependent variable.
Results: Univariate analysis of FGM and HCV showed a statistically significant
association with a Prevalence Odds Ratio of 4.82 (2.91 -7.96), after adjusting for age and
schistosomiasis injection, the association between FGM and HCV remained statistically
significant with an odds of 2.98 (1.76 – 5.05)Among the category for FGM performer
and association with HCV infection, the OR was 4.28 (2.31 – 7.91) when the FGM was
performed by a ghagaria, 3.68 (2.76 - 4.90) when the FGM was performed by daya, and
3.30 (1.81 -5.88) when the FGM was performed by a barber. Among other independent
variables, a lack of education, rural residence, and having religious precepts for FGM had
statistically increased odds of association with HCV infection.
Conclusion: There is a statistically significant association between FGM and HCV
infection. There are increased odds of HCV when the FGM is performed by providers
other than doctors. Participants from a rural residence and who those who did not have
any education were at increased odds of HCV. Subjects who believed in religious
precepts for FGM and also who answered that FGM can continue had increased odds of
association
with
HCV
infections.
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Chapter I
Introduction
1a. Background
Globally, the World health Organization (WHO) estimates that each year 3-4
million people are newly infected with Hepatitis C virus (HCV); 150 million live with
chronic infection and are at risk of developing cirrhosis or liver cancer; and 350,000
people die due to HCV related illnesses (WHO). Egypt has the highest prevalence of
Hepatitis C in the world (Lavanchy, 2009). According to the WHO, the rate of chronic
infection is 15% in Egypt, 4.8% in Pakistan, and 3.2% in China. The Egyptian Ministry
of Health Program(MOHP) has two kinds of programs: one largely aimed at treatment of
current chronic infections, and a second focused on prevention efforts to decrease HCV
transmission(Yahia, 2011). However, a majority of the resources are allocated to
treatment of HCV rather than prevention(Yahia, 2011). Yet, diagnosis and treatment lead
to complete recovery in only 60% of cases and alone do not prevent transmission(Kamili,
Drobeniuc, Araujo, & Hayden, 2012; Pawlotsky, 2004). Specific treatment for chronic
HCV in Egypt requires at least a 36 week regimen of interferon and ribavirin and costs
about US$ 3500, a price well above the Egyptian median income of US $ 2,070 per
person per year (Yahia, 2011). Perhaps, diverting some of the funds towards prevention
will offset the disease transmission, and the societal and economic burden of chronic
HCV.
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Focusing on prevention requires identification of major transmission risk factors and
taking actions to curtail their impact. HCV transmission occurs through percutaneous
exposure to infected blood (CDC). Given this fact that HCV can be transmitted through
infected blood, it is reasonable to explore cultural practices that involve bloodletting,
such as female genital mutilation, which is widespread in Egypt(El-Gibaly, Ibrahim,
Mensch, & Clark, 2002). FGM is defined by the WHO as “all procedures that involve
partial or total removal of the female genitalia, or other injury to the female genital
organs for non-medical reasons” (WHO).

Immediate complications of the FGM

procedure include minor to severe bleeding depending on the amount of tissue
excised(Momoh et al., 2001). FGM is a practice that is widespread in Egypt(El-Gibaly,
Ibrahim, Mensch, & Clark, 2002). FGM is practiced in the African continent stretching
from Senegal in the east, Egypt in the northeast and extends as far as Tanzania in the
south (Kouba & Muasher, 1985). Of the 140 million girls and women who are currently
living with FGM, 101 million reside in the African continent (WHO). The procedure is
usually performed by medically unqualified people, who sometimes use unsterile
instruments such as razor blades, knives, broken glass, sharp stones, or scalpels likely to
be contaminated with disease agents (Momoh, Ladhani, Lochrie, & Rymer, 2001; Slack,
1988). Since FGM can be performed using unsterile instruments, and also involves
bloodletting, we explored the association between FGM and HCV in Egypt.

2
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1b. Purpose of the study
The goal of this study is to add to the evidence of risk factors for HCV
seropositivity in Egypt, with a particular focus on FGM as a risk factor for hepatitis C.
Using Demographic Health Survey data from Egypt (EDHS) in 2008, the prevalence
rates of hepatitis C among women based on demographic, behavioral, and clinical
variables were examined. The study goals are:


To evaluate the association between HCV infection and FGM;



To determine possible relationships between HCV infection and the type of
provider who performs FGM (doctor, lay provider, etc.)



To examine possible associations between social-demographic factors and HCV
infection;



To assess the relationship between HCV infection and knowledge and attitudes of
women regarding FGM;



To analyze clinical/iatrogenic risk factors such as, a history of blood transfusion,
surgery, injection for schistosomiasis, etc., and their relationship with HCV.

3
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CHAPTER II

REVIEW OF LITERATURE
2a. Virology and pathophysiology
The term hepatitis refers to inflammation of the liver which can be caused by
infectious agents, such as viruses, or non-infectious agents, such as alcohol and drugs
(http://www.cdc.gov/hepatitis/). The five most common types of viral hepatitis are caused
by hepatitis A, B, C, D and E viruses, after which they are also named
(http://www.cdc.gov/hepatitis/). The Hepatitis C virus (HCV) is a member of the genus
Hepacivirus and the Flaviviridae family(Pawlotsky, 2004). The name HCV refers to any
of six main groups (clades 1-6) or any of a number of subgroups of enveloped, singlestranded RNA viruses(Pawlotsky, 2004). Each Hepatitis C virus or HCV contains one
polyprotein, which is processed in human liver cells or hepatocytes into structural (C, E1,
E2 and p7) and nonstructural (NS1-3, NS4A-B and NS5A-B) subunits. In addition to this
diversity in the types of HCV, HCV viruses are also highly mutative, with a mutation rate
of 10–3 per nucleotide per generation(Chisari, 2005) (Chisari, 2005).
Initial HCV infection is often asymptomatic and self-resolving in 20% to 50% of
cases by six months following infection(Pawlotsky, 2004). In most cases (50–80%), HCV
infection becomes chronic(Pawlotsky, 2004). Although much of the mechanism of
infection remains unknown, chronicity is impacted by weak CD41 and CD81 T-cell
responses in human cells during the acute infection phase(Pawlotsky, 2004). This weak
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response to the viral infection in some people could be due in part to the diversity of the
virus, its high replication rate (1012virions per day) and its ability to evolve new means of
evading host cell defenses quickly after infection due to its high mutation rate (Chisari,
2005). Indeed, it is unknown whether the inability to clear the virus in the first six months
in some people is due to antigen overload (resulting from all the factors previously
listed), changes to the normal viral detection by the host cell caused by the virus,
individual genetics or other factors(Chisari, 2005).
Even when chronic infection is established, HCV does not directly kill liver cells,
except in the case of one specific clade called the HCV3(Pawlotsky, 2004). HCV3
directly induces lesions or accumulation of lipids in the hepatocytes referred to as
steatosis(Pawlotsky, 2004). In most cases, steatosis is caused instead by locally driven
immune responses, which are mainly non-specific and lead to inflammation(Chisari,
2005). Constant inflammation leads to death of liver cells and triggers fibrogenesis or the
excessive buildup of collagen and other extracellular matrix constituents in the liver
(Pawlotsky, 2004). Cirrhosis or scarring of the liver develops with increasing buildup and
is facilitated by external factors, such as chronic alcohol consumption and viral coinfections, for example with HIV(Pawlotsky, 2004). Chronic infection with HCV causes
cirrhosis in 10–20% of cases after 10–20 years of infection, and hepatocellular carcinoma
or liver cancer in 1–4% of cases per year, in patients with HCV-related
cirrhosis(Pawlotsky, 2004). Chronic HCV is also associated with other systemic
conditions such as renal and skin diseases (Gumber & Chopra, 1995).

5
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2b. Diagnosis and treatment
Around the world, approximately 170 million people are infected with the virus.
When symptomatic, acute infection, or infection in the first six months of acquiring the
virus, can be characterized by nausea, vomiting, abdominal pain, fatigue, pale colored
stools and fever (Hoofnagle, 2003). However, only one-third of patients with acute
infection have clinical manifestations (Gumber & Chopra, 1995). In addition to showing
no clinical signs during the acute stage, about 50-80% of infected people go on to become
chronic cases(Pawlotsky, 2004). According to the CDC, of those with chronic HCV, 6070% of people show signs of liver disease, while many others who have chronic HCV
infection do not have apparent clinical signs and are not aware of their infection, which
allows

them

to

serve

as

a

major

reservoir

of

the

virus

(http://www.cdc.gov/hepatitis/HCV/HCVfaq.htm#a14). The transmission of HCV occurs
by contact with blood of an infected person(Pawlotsky, 2004).

HCV is highly

transmissible through repeated percutaneous exposure to infected blood, but any kind of
parenteral transmission, such as occupational and perinatal exposure, can also lead to the
transmission of HCV (http://www.cdc.gov/hepatitis/HCV/HCVfaq.htm#a14).
For

infected

people,

conclusive

diagnosis

of

HCV

is

somewhat

problematic(Kamili et al., 2012). A review by Kamili, Drobeniuc, Araujo and Hayden
(2012) describes the evolution of diagnosis of this virus. According to the review, in most
laboratories, the first step of diagnosis involves detecting the presence of antibodies, or
anti-HCV immunoglobulin G/IgG using assay, which is detectable after 8-9 weeks.
However, the presence of anti-HCV alone cannot distinguish acute from chronic
6
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infection, and cannot separate past infection that has already been cleared from current
infection definitively(Kamili et al., 2012). Per Kamili and colleagues, the gold standard
for the detection of current infection is the detection of HCV RNA through nucleic acid
testing (NAT). Due to the requirements for this particular procedure, including expert
technical staffs, expensive equipment and reagents, appropriate space and pristine serum
or plasma samples, most laboratories do not actually use this procedure(Kamili et al.,
2012).
If a person is successfully diagnosed with HCV, their treatment options are pretty
limited. Currently, interferon and ribavirin for a period of thirty six weeks is used, and
this is effective in clearing 60% of chronic HCV infections(Kamal et al., 2005).
Vaccination against HCV is not yet available(Chisari, 2005), and prophylaxis with
immunoglobulin is not effective after exposure already occurred(McGee, Cupell,
Higgins, Renshaw, & Shaver, 2001). Since there is no vaccine and no post-exposure
prophylaxis available, it is imperative to focus on methods to prevent the exposure from
occurring (Alter, 1997; Control & Prevention, 1998) ( http://www.cdc.gov).
2c. Women and HCV
In Egypt, several factors make women more susceptible to HCV than men,
including women being more limited in their knowledge of the causes and transmission
of this condition and the socio-economic disparities between the two genders. In Egypt’s
2008 DHS health survey, men and women who were tested for HCV between ages 15-59
were asked specific questions pertaining to their knowledge and attitudes about hepatitis
7
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C (El-Zanaty, Fatma, and Ann Way, 2009). Specifically, the survey questions included
those who had heard about HCV, their understanding about the modes of transmission
and prevention, and the sources from which they had received information. The test
results indicate that in general, men (85%) were relatively more knowledgeable about
hepatitis C than women (80%). Specifically, only 40% of female respondents were aware
that HCV can be transmitted by coming in contact with the blood of an infected
individual compared to 54% of males. Similar differences were found among men and
women in questionnaires about transmission of HCV through unclean needles.
In addition to a gap in knowledge between men and women, there is significant
evidence of a gender difference in the transmission of HCV. Wives were more likely to
transmit the virus to their husbands than vice versa (Magder et al., 2005). A cross
sectional serological survey was conducted to study the transmission of hepatitis C
among spouses in two communities of Egypt (Magder et al., 2005). In that study, the
probability of wife to husband transmission was 34% for HCV RNA positive wives and
10% for HCV RNA negative wives, due to the higher transmissibility of ongoing acute
infection. Interestingly, the probability of husband to wife transmission was lesser; 3%
for HCV RNA positive husbands to 0% for HCV RNA negative husbands. This study
suggests that women are better able to transmit the virus than men, but the reason is
unknown.
Similarly, the biological response of clearing the virus was significantly different
for females compared to male. Females were more efficient in clearing the virus as
8
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indicated by undetectable HCV RNA. (Bakr et al., 2006). The study showed that 44.6%
of females cleared the virus compared to 33.7% of males, after adjusting for potential
confounders. The above studies implicate that females are different than males in their
biological response to HCV. While there is increased vulnerability due to social
circumstances, there may be increased immunity biologically, though much more
research is needed to confirm this. Isolating prevention factors pertaining to women
opens up avenues for targeted public health approaches in preventing transmission of
HCV infections among women.
2d. Risk Factors
a. Transmission. The mode of transmission varies greatly between industrialized
and non-industrialized countries. In developed countries, intravenous drug abuse has been
documented as the most common risk factor for HCV infections (Shepard, Finelli, &
Alter, 2005). In the developing world, however, risk factors associated with increased
risk of transmission of HCV are unsafe therapeutic injections and blood transfusion from
unscreened blood donors (Shepard et al., 2005). A vast amount of literature shows
evidence of transmission of hepatitis C through therapeutic procedures. The relatively
recent discovery of HCV, much later than the advent of modern surgical and dental
procedures enabled the virus to be a classic example of iatrogenic transmissions. As a
result, clinicians are still seeing an increased rate of chronic hepatitis C among people
who had received blood transfusions in the past (Prati, 2006). Egypt’s high rate of
chronic HCV infections is attributed to iatrogenic infections caused during mass
campaigns against schistosomiasis (Frank et al., 2000). Mass campaigns, where a large
9
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number of people were given tartar emetic intravenously using glass syringes for about
30 years up until the 1980’s has resulted in an unprecedented rate of chronic HCV
infections, the highest in the world. However, other developing nations such as India
have also attributed chronic HCV to unsafe injection practices used to treat Kala-azar
(Singh, Dwivedi, Sood, & Wali, 2000). Therefore, unsurprisingly, HCV is the most
common cause of post-transfusion hepatitis.
b. Female Genital Mutilation [FGM]. The WHO has defined FGM as “all
procedures involving partial or total removal of the external female genitalia or other
injury to the female genital organs for non-medical reasons” (WHO).The WHO
classification of FGM is as follows: Type I – partial or total removal of the clitoris and/or
the prepuce (clitoridectomy); Type II – partial or total removal of the clitoris and the
labia minora , with or without excision of the labia majora (excision); Type III –
narrowing of the vaginal orifice with creation of a covering seal by cutting and
appositioning the labia minora and/or the labia majora, with or without excision of the
clitoris (infibulation); Type IV – all other harmful procedures to the female genitalia for
non-medical purposes, for example, pricking, piercing, scraping, incising, and
cauterization (Types of FGM).
The surgical practice of removing a part or all of the female external genitalia has
been practiced for hundreds of years. In Egypt, for example, this practice has been around
for more than a thousand years (Assaad, 1980). Dr. Meinardus, a sociologist, writes that
this practice probably originated in Egypt during the time of Pharaohs. Despite the nature
10
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of the practice itself, this practice has profound moral, societal and cultural significance.
Contrary to modern belief, many mothers prefer it for their daughters in order to build a
dignifying identity for them(Toubia, 1994). In an effort to find an explanation for the
FGM practice in Egypt, Meinardus suggests that it is related to the Pharaonic belief in the
bisexuality of gods;” just like the gods, every person has feminine and masculine souls,
the feminine part of male soul resided in the prepuce and the masculine part of the female
soul resided in the clitoris. Hence, in order for a man or woman to be fully grown up and
be accepted into manhood and womanhood, they had to shed their feminine and
masculine properties, respectively” (Meinardus, 1967).

Many women endure this

practice in order to gain respect and fulfillment in their societies and as a rite of passage
into adulthood (Assaad, 1980).
Given the historical nature of FGM, it is often performed by traditional midwifes
called Dayas or barbers using crude unsterile instruments, without anesthesia and with
insufficient knowledge of female anatomy, providing many opportunities for
transmission of infectious diseases (Diouf & Nour, 2012). A study using Demographic
Health Survey from Kenya in 2003, showed that women who underwent FGM had
higher odds of being HIV positive compared to their counterparts who did not go through
FGM (Maslovskaya, Brown, & Padmadas, 2009). However, though HCV and HIV have
similar transmission routes, some studies have shown no statistically significant
association between FGM and HCV (Habib et al., 2003). On the other hand, male
circumcision was found to have increased odds of association with HCV, which may be
11
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explained by the fact that males are sometimes circumcised in small groups using the
same instruments, unlike females in whom the procedure is generally performed
individually(Habib et al., 2003). In this study, the age adjusted OR for females who were
circumcised by an informal health provider for having HCV was 1.3 (0.5, 3.5), however,
this was not statistically significant (Habib et al., 2003).
c. Age. A number of host factors affect the natural history of chronic HCV;
among them age is one of the significant factors affecting the progression of disease
(Seeff, 2006). In a study involving 2235 patients with HCV, the progression of fibrosis
was closely associated with aging (Poynard, Bedossa, & Opolon, 1997). A crosssectional survey in a rural community of the Nile Delta region revealed that anti-HCV
prevalence increased sharply with age; in those <20 years old, anti-HCV prevalence was
9.3% compared to >50% prevalence in those older than 35 years (Abdel‐Aziz et al.,
2000). A multivariate regression analysis for independent risk factors of a community in
the Nile Delta region in Egypt also showed that age was an independent risk factor for
hepatitis C (Habib et al., 2003).
Age is not only associated with disease progression directly, but is also related
with knowledge of HCV, with schistosomiasis treatment campaigns and with FGM. Age
was significantly related to knowledge and attitudes about hepatitis C in the Egypt 2008
DHS data (EDHS)(El-Zanaty, 2009). According to the 2008 EDHS report, women
between the age groups of 20-39 years were more likely to have known about hepatitis C
than women younger or older. According to Arafa and colleagues (2005), the peak of
12
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anti-HCV prevalence among older adults aged 40-54 years corresponds to the aging
cohort of children who were infected through schistosomiasis campaigns in Egypt(Arafa
et al., 2005). FGM is a ritual usually performed between the ages of 4 to 10 years, and in
some communities it may be performed earlier (Toubia, 1994).
d. Education. The amount of education women have in general is related to their
knowledge of HCV in particular. The number of women knowing about hepatitis C was
much higher among women who had completed secondary or higher education (ElZanaty, 2009). According to EDHS report 2008, 93.4% of women with “secondary
education/higher” knew at least one of the ways in which the illness could be spread
compared to only 54.2% of women who had “no education”(El-Zanaty, 2009). In a study
involving a village with moderately high prevalence of hepatitis C in Upper Egypt, the
risk of hepatitis C for those above 30 years old was higher among those who never
attended college (Medhat et al., 2002).
e. Marital status. Some believe marriage is a surrogate marker for the sexual
transmission of HCV; however, this view has been controversial, since several studies
reported similar, rather than higher, prevalence of HCV among heterosexuals married
couples and men who have sex with men (MSM) (ANNEMARIE WASLEY & Alter,
2000). MSM are usually considered a riskier sexual group and would be expected to have
higher prevalence if the primary mode of infection was in fact sexual (Weasley& Alter,
2000). Whatever the reason, being married seems to be a risk factor for HCV. A
community study of a rural village of Upper Egypt showed that the risk of seropositivity
13
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significantly increased with marriage (Abdel‐Aziz et al., 2000; Habib et al., 2003). In this
study, the odds ratio of seropositivity with marriage was 4.1 (2.4-6.9) (Abdel‐Aziz et al.,
2000; Habib et al., 2003). Another assessment of the epidemiological pattern of
transmission in a community of the Nile Delta region of Egypt reported that the odds
ratio of marriage and increased risk of infection was 2.5, (1.0-6.1) (Arafa et al., 2005). A
study in Taiwan also concluded that the risk of transmission increases with marriage and
duration of marriage (Memon & Memon, 2002). The Taiwanese study found that infected
couples were more likely to have shared toothbrushes and to have had more frequent
sexual contacts.
f. Cesarean section. Physiologically, the placental barrier acts a shield to protect
the baby from several pathogens, but this protective shield is compromised during
miscarriage, abortion, labor, and child birth. Data from HCV positive pregnant women
suggests that perinatal transmission of HCV occurs around the time of delivery (Mok,
Pembrey, Tovo, & Newell, 2005). In one study of 441 mother-child pairs from the UK
and Ireland followed through pregnancy and delivery, the findings concluded that a
cesarean section before membrane rupture had a decreased risk of peripartum
transmission than vaginal delivery (Gibb et al., 2000). However, whether or not cesarean
section is a risk factor in the transmission of HCV in Egypt remains a controversy. A
study of risk factors in rural areas of Egypt concluded that instrumental delivery
(cesarean sections, episiotomy, ventouse) was associated with a 3.49 (1.12-10.9) fold
increased risk of HCV transmission (Arafa et al., 2005). Another study of risk factors in
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the Nile Delta region concluded that mothers who had cesarean sections or abortion had a
OR of 1.4 (1.0, 1.9) for transmission of HCV (Habib et al., 2003).
g. Type of residence. The place of residence is an indirect measure for several
health indices, such as, access to healthcare services, education, socio-economic
conditions, and various cultural practices that may be associated with decreased or
increased risk of infections (Eberhardt & Pamuk, 2004). Several factors play a role in the
pathogenesis of HCV in relation to the residence. One such factor is the relationship
between place of residence and prevalence of schistosomiasis.

The more rural Lower

Egypt has always had a higher rate of schistosomiasis than Upper Egypt; whereas, the
rates in Upper and Middle Egypt increased only as a result of conversion from basin to
perennial irrigation which accelerated the transmission of schistosomiasis. The city
dwellers of Upper Egypt and the areas surrounding Alexandria have lower rates of
schistosomiasis potentially explaining why rural areas have higher prevalence of HCV
than urban areas of Egypt(Frank et al., 2000). Currently, HCV prevalence correlates
closely to schistosomiasis prevalence in all parts of Egypt, and many blame Iatrogenic
transmission (Frank et al., 2000).
h. Type of FGM provider. In Egypt, FGM has been traditionally performed by
traditional midwives known as Daya, gypsies known as Ghagharia, and also by a barber.
A study conducted in Egypt showed that the age adjusted risk for females circumcised by
an informal healthcare provider such as a barber or traditional birth attendants(TBA) is
1.6 (0.7 – 3.8) (Medhat et al., 2002). However, this significance was lost in multivariate
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analysis. These results are consistent with another study of a community in the Nile Delta
region in which the risk of HCV for those who underwent FGM by an informal health
provider was 1.3 (0.5 – 3.5) (Habib et al., 2003). Similar to these 2 studies, another study
of pregnant women in Egypt found that there is a 1.43 (1.03 – 1.98) times increased risk
of hepatitis C, when circumcision was done by a TBA or barber (Stoszek et al., 2006).
The government allowed the practice to be performed by medical practitioners for a
period of time during the mid-nineties but banned FGM after the death of a 11 year old,
who bled to death after being circumcised by a barber (Wiens, 1996). The brief
institutionalization of FMG led to medicalization of this practice. Thereafter,
medicalization has been fiercely debated by some as a harm-reduction practice that
improves safety of FGM and thereby health of women (Shell-Duncan, 2001). Other
studies have reported medicalization as one of the factors fueling the growth of the
practice (Ugboma, Akani, & Babatunde, 2004).
i. Religious and cultural beliefs. There is limited evidence of religious precepts
to the practice of FGM, although, often ignorantly, it is cited as a reason (Assaad, 1980).
The practice is rooted in the belief that FGM moderates sexuality in women, that it
enhances the marriageability for girls, prevents adultery, and helps maintain virginity(ElGibaly et al., 2002; Toubia, 1994). Since religious precepts strongly support these moral
values, FGM is commonly used in conjunction with religion(Slack, 1988). FGM was in
practice before the advent of Abrahamic religions; since people had earnest beliefs about
this cultural practice, overtime, it has become embedded in the African tradition and
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religion (Slack, 1988). Although, the Islamic religion is often cited for strengthening the
practice; it is to be noted that FGM is not practiced in a great majority of Muslim
countries (Wiens, 1996). Furthermore, FGM is a practice that is embedded in many
religious cultures in Africa (Slack, 1988).
j. Lifetime History of Medical Procedure and Injections. Since its discovery in
1989, many developed countries implemented screening for HCV in the early 90’s(Hibbs
et al., 1993). However, many developing countries did not practice screening of donor
blood for HCV until recently.

Early nineties signaled the presence of transfusion

associated hepatitis to be very high among Egyptian blood donors(Saeed et al., 1991). In
contrast to the United States, where volunteer blood donors had about 1-4% anti-HCV,
unpaid blood donors of Egypt were found to have anti-HCV prevalence rates of about 1122% (Abdel-Wahab et al., 1994). A study comparing the prevalence of HCV among
transfused and non-transfused children in Egypt reported the prevalence of anti-HCV to
be 55% in the study population, and among these children 92% had history of multiple
blood transfusions for hematologic disorders(Khalifa, Mitchell, Watts, El-Samahy, & ElSayed, 1993).
Injection drug use has been established as a common mode of transmission of
HCV, and a large proportion of respondents of EDHS had received injections(El-Zanaty,
2009). About 8 percent reported that they received injection for schistosomiasis and 93
percent reported that they have received injection for some other purpose. Of the
respondents, 4 out of 10 reported that the syringe or needle used for at least one of the
17

18

injection that they received was reused (El-Zanaty, 2009). Despite varying purposes for
receiving and sharing injections, the risk of transmission of HCV in a country with a
large reservoir of chronic infection is universally high (Hagan et al., 2001; Thorpe et al.,
2002). In a study of risk factors for seropositivity, dental treatment was associated with a
slightly increased, though statistically insignificant risk of HCV (Abdel‐Aziz et al.,
2000). However, studies from other countries have reported extensive contamination of
dental equipment after treatment of patients with hepatitis C (Piazza et al., 1995).
2d. Summary
Receiving treatment for Schistosomiasis has been a well-established risk factor in
the transmission of HCV in Egypt and played a significant role in the current
epidemiology of chronic HCV infections. Furthermore, older age group is a significant
risk factor for HCV; this corresponds to the cohort of the ageing population who received
Schistosomiasis treatment between 1960 and 1980. There was a clear association between
marital status and HCV, with the risk of HCV increasing with the duration of marriage,
which supports the hypothesis that HCV can be sexually transmitted. The role of FGM in
the epidemiology of HCV has not been well established, and there is a limited literature
suggesting an association between these two variables. However, there is some evidence
to support the transmission of HCV when it is performed by an untrained, nonmedical
professional. Lifetime history of blood transfusions has been a well-established risk
factor in Egypt. Although studies from other countries have shown evidence of
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associations between HCV and dental treatment, surgeries and injection sharing, there is
limited evidence to support this hypothesis among the Egyptian population.
The literature review examined the risk factors associated with the transmission of
HCV infection. Emphasis was given to studies focusing on associations between HCV
and FGM. However, a comprehensive review of general risk factors associated with the
transmission of HCV has been included. Aligning with the overarching goal of this
thesis, a general analysis of health consequences related to FGM has also been included.
The literature review was used as guidance for the variables used in the analysis.
2e. Theoretical Basis of the Study
The burden of HCV in human physiology and economy arises from its effect to
produce chronic disease; hence, this study evaluates the risk factors of HCV the Life
Course Perspective as a theoretical model for chronic disease (Ben-Shlomo & Kuh, 2002;
Hall, Yee, & Thomas, 2002). This theory acknowledges the presence of biological,
behavioral, and psychosocial pathways that operate across all stages of an individual’s
lifespan to cause and modify disease. This theory postulates that there is a cumulative
burden of risk due to psychosocial and cultural determinants that influence an
individual’s chances of acquiring disease. Therefore, women from certain psychosocial
backgrounds have an increased risk of acquiring HCV and suffer from chronic sequel due
to infection.
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CHAPTER III
METHODOLOGY
3a. Data Sources and Study Population
The source of data for the study came from the Demographic and Health Survey
of Egypt for 2008, otherwise known as EDHS 2008. The 2008 EDHS is the ninth in this
series of surveys conducted in Egypt. According to EDHS 2008 report, the goal of the
2008 EDHS is to provide estimation of key health indicators; such as fertility, use of
contraceptives, infant and child mortality, immunization levels, maternal and child health,
and nutrition. In order to achieve this goal, nationally representative sample of 16,527
“ever-married” women between the ages of 15-49 were interviewed. Additionally, the
2008 EDHS also collected information of specific health issues that were relevant to the
population of Egypt. One in four households from the sample was chosen for the health
issues survey; 6,578 women and 5,430 men between the ages of 15-59 were interviewed.
The key topics covered in the health issues subsample were knowledge and awareness of
HIV/AIDS and hepatitis C, avian influenza, history of hypertension, cardiovascular
illness, diabetes and liver disease. The survey also covered knowledge and attitude
related to female circumcision, healthcare costs and health insurance coverage and
collected specimens from the subsample to be tested for HIV and Hepatitis C (Fatma ElZanaty, 2008).
DHS is a survey funded by USAID in less developed countries. DHS uses a
standardized model of questionnaire across all countries that are included. Each question
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has a particular code to maintain standardization across all countries. Surveys are
typically conducted once every four years, and a report of key population indicators is
published after each survey. Results of the research survey are then disseminated through
seminars, web-based tools and other technologies and can then be further used for
program design and evaluation. DHS caters these tools to a wide range of audiences
including researchers. For the purpose of this study, the individual, household and
biomarker data files from EDHS 2008 were used. All women who were interviewed for
the health issues subsample and underwent lab testing for Hepatitis C were included in
the analysis.
Unlike the other two data files used for the study, the biomarker data file did not
have a “CASEID” number. Hence, an identification number was created by
concatenating the cluster number, household number and line number. The files were
then merged using the key variables.
3b. Study measures
a. Dependent variable. HCV status was used as the main dependent variable
throughout the analysis. HCV status was determined based on the results of the
biomarker data file; women who tested positive for the HCV antigen were further tested
for the presence of HCV RNA. Women who had a positive test result in either one of
these tests were coded as being positive for HCV. This variable was computed from the
variable named “OB03A” and “OB03B” from the biomarker data file and was originally
labeled as Blood test result: Antigen for HCV, and Blood test result: HCV RNA,
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respectively. HCV status was used as the main dependent variable throughout the
analysis. All women between the ages of 15-59 who underwent Hepatitis C testing were
included in the analysis, unless their test results showed to be “indeterminate”, making it
unclear whether such women were positive or negative for HCV infection. The
prevalence of Hepatitis C among women was determined through the study.
b. Independent variables. The variables that were included in the study were
obtained from the individual file. These measures were categorized as socialdemographic variables, behavioral variables relating to FGM, and clinical/iatrogenic
variables that have potential associations for HCV infection. Social demographic
variables included age, education, marital status, and type of residence; behavioral
variables included whether or not the woman had FGM, and questions relating to
knowledge and beliefs associated with FGM; clinical variables included history of blood
transfusion, surgery,

history of sharing syringes or injections, history of receiving

injections for schistosomiasis.
Social - Demographic Measures
Age. Age was obtained from the variable labeled age of respondent
calculated. This measure had been calculated using the date of birth of the subjects who
were surveyed in EDHS 2008. Age was a measure in whole number; this measure was
then recoded into a categorical variable of five categories as follows; age 15-19, age 2029, age 30-39, age 40-49, and age 50-59.
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Education. Education was categorized into the following groups; no education,
some primary, primary complete/some secondary and secondary complete/higher.
Marital status. Marital status was categorized as follows: married, widowed,
divorced, separated, signed contract, and never married. All those who were married,
widowed, divorced, or separated were re-coded as “ever-married” and those who had
signed contract for marriage and never married were re-coded as “never married”.
Residence. Residence was categorized as urban or rural.
Measures Relating to Attitude and Behavior
History of FGM. The survey questionnaire stated “have you yourself been
circumcised”? The responses were either yes or no and were coded 1 and 2, respectively.
Those who answered “no” were used as a reference value in analysis. Those who
answered don’t know were coded as a discrete missing value.
FGM performer. Information about the person who performed the FGM was
obtained from question I204 of the individual file. The responses were coded as follows:
1 for doctor, 2 for a nurse/health practitioner, 3 for daya, 4 for barber, and 5 for ghagaria.
Those who answered “don’t know” were coded as a discrete missing value.
Religious beliefs associated with FGM. This measure was obtained from
question #I209 of the individual file. The responses were either “yes”, “no”, or “don’t
know”; and were coded 1, 2 and 8, respectively. Those coded as 8 were recoded as a
discrete missing value.
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Belief that FGM can continue. The original code for this question was # I210
from the individual file of EDHS 2008. An affirmative response was coded as 1 and a
negative response was coded as 2. All the women who answered “don’t know” were
coded as a discrete missing value.
Measures associated with potential clinical/iatrogenic risk factors for HCV
History of Blood transfusion. The question was originally labeled have you ever
had a blood transfusion. A positive response was coded as 1 and a negative response was
coded as 2. [# I501B] This response and coding was the same for all clinical measures
stated below.
History of Surgery. A history of any surgery in the past was stated in the
questionnaire as, “Ever had any surgery in the past”? [# I501A].
History of sharing needles or syringes. EDHS questionnaire # I504 was used to
identify this variable; the questionnaire stated, “Was the same needle or syringe used by
somebody”?
History of injection for schistosomiasis. This question was stated as follows:
“ever received any injection for schistosomiasis”? [# I502A].
3c. Statistical Analysis
The statistical package for Social Sciences [SPSS] version 21 was used to
truncate, organize and analyze the data from EDHS 2008 to make it suitable for the
study. Frequency tables to determine the distribution of HCV status across these variables
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were cross tabulated with same. The estimation of HCV infection between different
categories of study measures were compared using the Pearson Chi-square test, and
univariate and multivariate logistic regression analyses were performed to estimate the
factors associated with HCV positivity. HCV status was used as the dependent variable in
all models [Coded as 1 for positive and 0 for a negative result]. The following
independent variables were categorized: age, education, marital status, residence, history
of FGM, FGM performer, religious belief for FGM, belief that FGM can continue,
history of blood transfusion, history of surgery, history of sharing needles or syringe,
history of injection for schistosomiasis. A P-value of <0.05 and a confidence interval of
95% were used to determine statistical significance throughout the analysis.
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Chapter IV
Results
4a. Sample Demographics
The total number of EDHS respondents who met the study eligibility criteria was
6569 out of which 711 were found to be HCV positive. The demographic profile of
participants with respect to independent variables is presented below in table 1. About
32% of respondents were between the ages of 20-29, making this the largest category
among all age groups. Around 40% of the respondents had completed secondary or
higher education, 74% were married and 58% resided in a rural area. An overwhelming
90.9% of respondents had a history of FGM; 52% believed in religious precepts for
FGM; and 56% believe that the practice can continue. Only 4.2% of respondents had a
history of blood transfusion, while 45.9% had a history of surgery. Similarly only3.8%
had a history of sharing needles or syringes, and only 5.1% had received injection for
schistosomiasis.
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Table 1: Sample Size and percentage of women included in the study from
EDHS 2008
Variables
Age
15-19
20-29
30-39
40-49
50-59
Education
No education
Some primary
Primary complete/some secondary
Secondary complete/higher
Marital Status
Ever married
Never married
Residence
Urban
Rural
History of FGM
Yes
No
Religious belief for FGM
Yes
No
Belief that FGM can continue
Yes
No
History of blood transfusion
Yes
No
History of surgery

N

%

1106
2110
1447
1161
754

16.8
32.1
22.0
17.6
11.5

2048
536
1378
2616

31.1
8.1
20.9
39.8

4914
1655

74.8
25.2

2745
3824

41.8
58.2

5962
600

90.9
9.1

3434
1895

52.3
28.8

3683
2156

56.1
32.8

276
6276

4.2
95.5

Yes

3012

45.9
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No
History of sharing needle or syringe
Yes
No
History of injection for Schistosomiasis
Yes
No

3547

54

252
5679

3.8
86.5

332
6136

5.1
93.4

4b. Distribution of variables across HCV status
The distribution characteristics of eligible participants across HCV status is
shown in Table 2. There were statistically significant differences between subjects who
were HCV positive and those who were HCV negative with respect to age, education,
marital status and residence(P <0.05). As shown, the age group of 40-49 represented the
cohort with the largest HCV positive people compared to other age categories that were
investigated. The highest proportion of HCV positive people were in the no education
group (54.6%), followed by the secondary complete/higher category (22.2%), primary
complete/secondary category (12.1%) and some primary (11.1%). The ever married
group and rural residents had higher proportions of HCV positives than their respective
counterparts. The groups with affirmative responses to history of FGM, religious precept
to FGM, belief that FGM can continue, blood transfusion, surgery, sharing needles and
injection for schistosomiasis all had higher proportions of HCV positives than their
respective counterparts. There was a statistically significant difference between the HCV
positive and negative groups across all variables.
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Table 2: Distribution characteristics of participants by HCV status; the P-value
signifies difference between HCV positive and negative groups
Variable
Age category
15-19
20-29
30-39
40-49
50-59
Education
No education
Some primary
Primary complete/some secondary
Secondary complete/higher
Marital Status
Ever married
Never married
Residence
Urban
Rural
History of FGM
Yes
No
Religious belief for FGM
Yes
No
Belief that FGM can continue
Yes
No
History of blood transfusion
Yes
No
History of surgery
Yes
No

HCV positive
%

HCV
negative%

3.9
14.2
21.1
32.5
28.3

18.4
34.3
22.1
15.8
9.4

54.6
11.1
12.1
22.2

28.3
7.8
22.0
41.9

Pvalue
<0.05

<0.05

<0.05
91.8
8.2

72.7
27.3
<0.05

26.0
74.0

43.7
56.3
<0.05

97.7
2.3

90.0
10.0

77.8
22.2

62.8
37.2

79.4
20.6

61.1
38.9

6.9
93.1

3.9
96.1

<0.05

<0.05

<0.05

<0.05
52.5
47.5

45.1
54.9

<0.05

History of sharing needles or
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syringe
Yes
No
History of injection for
schistosomiasis
Yes
No

6.0
94.0

4.0
96.0
<0.05

10.9
89.1

4.4
95.6

4c. Association between FGM and other independent variables with HCV status
Results of the univariate analysis of the association between independent variables and
HCV are shown in Table 3. In the univariate model, subjects who have had FGM had
4.82 (2.91 – 7.96) increased odds of HCV compared to those who did not have FGM. A
linear increase in odds of HCV with increasing age was apparent and ranged from 1.94 to
14.10 in subjects in the 20-29 to 50-59 age categories, respectively. The results of
univariate analysis also showed that lack of education and primary education were
associated with increased odds of HCV compared to subjects who have completed
secondary education, OR of 3.64 (3.00, 4.43) and 2.69 (2.02, 3.59), respectively. Ever
been married and rural residency was each associated with increased odds of HCV, OR
of 4.22 (3.21-5.55) and 2.21 (1.85-2.63), respectively. A religious belief for FGM and a
positive response for FGM can continue are also associated with 2.08 (1.69 – 2.55) and
2.45 (2.01 – 3.00), respectively, increased odds of HCV infection. Iatrogenic factors such
as a positive history of blood transfusion, surgery, sharing needles, and a history of
schistosomiasis is associated with 1.84 (1.34 – 2.53), 1.35 (1.15 – 1.57), 1.51 (1.07 –
2.15), and 2.63 (2.01 – 3.45), respectively, increased odds of HCV infection.
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Table 3: Association of FGM and HCV status; the OR (95% CI) represents the odds
ratio after univariate analysis
Variable
History of FGM
Yes
No
Age category
15-19
20-29
30-39
40-49
50-59
Education
No education
Some primary
Primary complete/some
secondary
Secondary complete/higher
Marital Status
Ever married
Never married
Residence
Rural
Urban
Religious belief for FGM
Yes
No
Belief that FGM can continue
Yes
No
History of blood transfusion
Yes
No
History of surgery
Yes
No

OR (95% CI)

P-value

4.82 (2.91 – 7.96)
Reference

<0.05

Reference
1.94 (1.27-2.96)
4.46 (2.95 -6.72)
9.58 (6.41-14.32)
14.10 (9.37-21.21)

<0.05
<0.05
<0.05
<0.05

3.64 (3.00 - 4.43)
2.69 (2.02 - 3.59)
1.04 (0.79 - 1.36)

<0.05
<0.05
>0.05

Reference
4.22 (3.21 – 5.55)
Reference

<0.05

2.21 (1.85 - 2.63)
Reference

<0.05

2.08 (1.69 – 2.55)
Reference

<0.05

2.45 (2.01 – 3.00)
Reference

<0.05

1.84 (1.34 - 2.53)
Reference

<0.05

1.35 (1.15 – 1.57)
Reference

<0.05

History of sharing needles or
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syringe
Yes
No
History of injection for
schistosomiasis
Yes
No

1.51 (1.07-2.15)
Reference

<0.05

2.63 (2.01 - 3.45)
Reference

<0.05

4d. Association of FGM and HCV status in multivariate analysis
Based on the univariate analysis and literature review, age and schistosomiasis
injection were controlled for in the multivariate analysis shown in table 4 below.
Adjusting for age and schistosmiasis injection, the odds of association between FGM and
HCV infection decreased from 4.82 to 2.98 (1.76 – 5.05). Other independent variables
that had a statistically significant association with HCV status were education, residence,
and beliefs. Adjusting for age and schistosomiasis injections, participants who lacked
education had increased odds of association with HCV infection compared to those who
completed secondary education with an OR of 2.08(1.68 – 2.57). Living in a rural
residence also had a statistically significant association with HCV infection with OR of
2.60 (2.16 – 3.14), compared to urban residents. After adjusting for age and
schistosomiasis injection, religious beliefs and an affirmative response to FGM can
continue each had increased odds of association with HCV infection with OR of 1.53
(1.23 – 1.89), and 1.69 (1.37 – 2.10), respectively.
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Table 4: Association of FGM and HCV infection after adjustment for age and
schistosomiasis injection
Variable
History of FGM
Yes
No
Education
No education
Some primary
Primary complete/some
secondary
Secondary complete/higher
Marital Status
Ever married
Never married
Residence
Rural
Urban
Religious belief for FGM
Yes
No
Belief that FGM can continue
Yes
No
History of blood transfusion
Yes
No
History of surgery
Yes
No
History of sharing needles or
syringe
Yes
No

OR (95% CI)

P-value

2.98 (1.76 – 5.05)
Reference

<0.05

2.08 (1.68 – 2.57)
1.57 (1.15 – 2.14)
1.22 (0.91 - 1.62)

<0.05
<0.05
>0.05

Reference
1.39 (0.98 – 1.98)
Reference

>0.05

2.60 (2.16 – 3.14)
Reference

<0.05

1.53 (1.23 – 1.89)
Reference

<0.05

1.69 (1.37 – 2.10)
Reference

<0.05

1.35 (0.96 – 1.91)
Reference

>0.05

1.05 (0.89 – 1.25)
Reference

>0.05

1.33 (0.91 - 1.95)
Reference

>0.05
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Table 5: Association between various categories FGM performer and HCV infection
in the univariate model

Variable
OR (95% CI)
FGM performer
Reference
Doctor
2.53 (1.65 – 3.89)
Nurse/other health provider
3.68 (2.76 – 4.90)
Daya*
3.30 (1.85 – 5.88)
Barber
4.28 (2.31 – 7.91)
Ghagaria*
*Daya – traditional midwife; * Ghagaria – Gypsy

P - value

<0.05
<0.05
<0.05
<0.05

4e. Association of FGM performer and HCV infection
Table 5 shows comparison of odds of HCV across performer of FGM using Doctors as
reference (Figure1). As shown, subject who received FGM from non-physicians had a
much increased odds of HCV. Compared to doctors, subjects who received FGM from
nurses, Daya, Barbers and Ghagaria had 2.53(1.65 – 3.89), 3.68(2.76 – 4.90), 3.30(1.85 –
5.88) and 4.28(2.31 – 7.91) increased odds of HCV, respectively.

34

35

Figure 1: Association of various FGM performer and HCV infection

*Daya – traditional midwife; * Ghagaria - Gypsy

Table 6 shows the association for FGM performer and HCV infection in the multivariate
analysis. As shown, after adjusting for age and injection for schistosomiasis, subjects
who received FGM from nurses and daya had increased odds of 1.75 (1.12 – 2.74), and
1.66 (1.22 – 2.27), respectively.
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Table 6: Association of FGM performer and HCV infection after adjusting for age
and injection for schistosomiasis
Variable
OR (95% CI)
FGM performer
Reference
Doctor
1.75 (1.12 – 2.74)
Nurse/other health provider
1.66 (1.22 – 2.27)
Daya*
1.51 (0.82 – 2.76)
Barber
1.33 (0.69 – 2.58)
Ghagaria*
*Daya – traditional midwife; * Ghagaria - Gypsy
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P - value

<0.05
<0.05
>0.05
>0.05

37

Chapter V
Discussion and Conclusion
5a. Discussion
Studying factors associated with HCV infection play an important role in
facilitating programs that target prevention. HCV in Egypt has been quoted as a
socioeconomic disease that is attributable to social practices that can be prevented
through infection control in the healthcare industry (Yahia, 2011). Further, treatment of
chronic HCV in Egypt has a cost higher than the median income rate of Egypt(Yahia,
2011). Hence; there is an urgent need for prevention to reduce the societal, economic and
health burden of the disease. There are a few studies that have studied associations of
female circumcision and Hepatitis C; however, not many have utilized a nationally
representative population of Egypt. This is particularly important since prevention of
hepatitis will not only reduce the burden of disease in women, but may also have an
impact in reducing the risk of transmission in their sexual partners and offspring. There is
also a limitation in the literature, associating FGM with HCV; therefore, this study is
significant in implicating this traditional practice, which may play a role in decreasing the
incidence of HCV, particularly in women.
Association between HCV infection and FGM
The study objective was to find the association between FGM and chronic HCV
in Egypt using EDHS 2008. The study utilized self-reported female circumcision and
laboratory measures to detect the prevalence of HCV. The main question of the study was
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whether prevalence of HCV was different in women who had FGM compared to women
who did not have FGM. The unadjusted OR of HCV for women who had FGM was 4.82
(2.91 – 7.96); and after adjustment for age and schistosomiasis injection, the OR was 2.98
(1.76 – 5.05). The OR obtained in this study is higher than the estimates obtained from
other studies. In a study by Habib et al, the age adjusted OR for females who were
circumcised by an informal health provider was 1.3 (0.5, 3.5), however, this was not
statistically significant(Habib et al., 2003). Although Schistosomiasis has been a wellestablished factor for the current prevalence rates of HCV, our study consistently also
showed an association of FGM with HCV infections (Frank et al., 2000). This finding is
in contrast to the study by Medhat et al, which concluded that circumcision per se was
not associated with HCV(Medhat et al., 2002). The question we attempted to answer is
whether there was an association between FGM and HCV even after controlling for all
known confounders from the literature and univariate analysis. This is significant because
it shows that there is a direct relationship between FGM and HCV infections. However, it
should be noted that we did not look at the effect of transmission of HCV through other
possible routes such as C-sections and episiotomy during childbirth.
Relationship between HCV infection and the type of provider who performs FGM
The variable “FGM performer” was used in univariate logistic regression analysis
with the objective of answering whether there was a difference in association between
HCV status, when it was performed by traditional midwives called daya, gypsies who are
called ghagaria, and barbers.

Among all categories of people performing the
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circumcision, FGM performed by a nurse/other health provider had the lowest OR of
2.53 (1.65 – 3.89). Among all unskilled professionals, FGM performed by ghagaria had
the highest OR for HCV of 4.28 (2.31 – 7.91). Circumcision performed by barber and
daya had a POR of 3.30 (1.85 – 5.88), and 3.68 (2.76 – 4.90), respectively. These ORs
are all higher than ones reported by Medhat et al. (2002) which found that the age
adjusted OR for HCV and female circumcision when performed by informal providers
was 0.4 (0.2 – 1.2) and by Stoszek et al (2006), were it was concluded that being
circumcised by a barber or traditional birth attendant was associated with HCV with an
OR of 1.53 (0.94 – 2.57). The OR reported by Habib et al. (2003) for circumcisions by an
informal health provide,OR of 1.7 (1.00 - 3.00), was the closest to the current study
results found in the literature, but the former finding was only applicable to boys over
20.Although many of the findings from the literature have not shown statistical
significance, the findings from this study suggest increased odds for HCV when the
circumcision is performed by a daya, ghagaria, or barber. Adjusting for age and
schistosomiasis injection, the association of HCV when FGM performer was a nurse or a
daya remained statistically significant. The adjusted OR was 1.75 (1.12 – 2.74) and 1.66
(1.22 – 2.27), respectively. In light of these results, it is arguable whether or not
“medicalization” or legally allowing female circumcision to be performed by medical
professionals may decrease the incidence of disease (Shell-Duncan, 2001). The secondary
goal of this study was to assess the relationship between FGM and HCV and we found
that there is in fact a relationship between the provider and HCV. Medical professionals
have the lowest odds of association with HCV. An additional benefit of using medical
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provider is the opportunity of educating women of the risks associated with the practice
of FGM. This is significant because of ongoing argument of medicalization; however,
despite reduced risk of HCV when FGM is performed by medical profession, the risk of
contracting HCV from FGM is still present. FGM is a risk, and if a ban was possible
might be the best course of action, and in its absence, allowing the medical profession to
conduct FGM reduces the transmission of HCV infections. The potential side effect of
medicalization is institutionalization of the practice of FGM; however, there is an
opportunity for providing counseling for women through the medical profession in
addition to reduction of HCV transmission.
Associations between social-demographic factors and HCV infection
Age consistently emerged as a variable that was strongly associated with HCV in
women. There was a linear increase in odds of association with HCV across the age
categories 30-39, 40-49, 50-59 with OR of 4.46 (2.95 – 6.72), 9.58 (6.41 -14.32) and
14.10 (9.37 -21.21), respectively. This is consistent with the finding that those who may
have received schistosomiasis injections as children currently belong to this aging cohort
of adults(Arafa et al., 2005). Even after adjustment for age and schistosomiasis injection,
education was a variable of statistical significance. Subjects who had no education and
those with some primary education had increased odds of association for HCV infection
compared to women who had completed secondary education or higher, with an OR of
2.08 (1.68 – 2.57) and 1.57 (1.15 – 2.14), respectively. Although the association between
education and HCV has not been particularly studied, there have been studies associating
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health, in general, with education(Lleras-Muney, 2005; Lynch, 2003), which suggests
that education plays an important role in accessing healthcare, cost of living, socioeconomic status and so forth. Our study results could be explained by this theory that
education may play a role in any disease outcome. The association between marital status
and HCV infection did not show statistical significance in either the univariate or
multivariate models in our study. This is inconsistent with the finding by previous studies
which showed a significant association between marriage and HCV (Abdel‐Aziz et al.,
2000; Arafa et al., 2005; Habib et al., 2003). The finding that rural residence had
increased odds of association with HCV is consistent with the study by Frank et al; in our
study, subjects residing in rural areas had an OR of 2.60 (2.16 – 3.14) after adjusting for
age and schistosmiasis injection(Frank et al., 2000).
Relationship between HCV infection and knowledge and attitudes of women
regarding FGM
This measure is one of the unique natures of this study due to a limitation in the
literature with regards to people’s beliefs regarding circumcision and how this affects the
transmission of HCV. The most common reasons for FGM were religious beliefs and to
follow the ancestral culture (Assaad, 1980). Adjusting for age and schistosomiasis, the
OR for the association between HCV and religious belief is 1.53 (1.23 – 1.89), and the
OR for HCV and an affirmative response for FGM can continue is 1.69 (1.37 – 2.10).
This result is supported by a study done by Sayed et al. (1996) which found that 92% of
mothers who allowed their daughters to be circumcised were illiterate and additionally
the most prevalent reason for the practice was because it followed customs and beliefs
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(Sayed, El-Aty, & Fadel, 1996). Therefore, this finding raises concerns about whether
abolition of the practice is feasible in the near future and whether medicalization can
provide a solution to decrease the incidence of HCV infection (Shell-Duncan, 2001).
Prevention programs should take into the consideration the fact that most people wish to
continue the practice, and therefore should not focus on eradication or banning of the
practice per se. For instance, a law banning this practice may not be effective in curtailing
the practice but could instead lead people to obtain services from less sanitary
knowledgeable providers such barbers and gypsies. Perhaps to facilitate the reduction of
HCV transmission associated with FGM, religious leaders and medical professionals
could serve as counselors to local people. Religious leaders are key stakeholders since
many people have religious precepts for FGM.
Analysis of clinical/iatrogenic risk factors such as a history of blood transfusion,
surgery, injection for schistosomiasis, and injection sharing, and the relationship
with HCV infection
Consistent with the literature from the early nineties, the results from our study
showed a statistically significant relationship of blood transfusion with HCV, with an OR
of 1.84 (1.34 – 2.53) (Abdel-Wahab et al., 1994; Hibbs et al., 1993). However, after
adjusting for age and schistosomiasis injection, this relationship between blood
transfusion and HCV infection was no longer statistically significant. An analysis of the
relationship between surgery and HCV infection, revealed an association between history
of surgery and HCV, OR of 1.35 (1.15 – 1.57). Although intravenous drug use (IVDU) is
uncommon in Egypt, sharing medical equipment and syringes are culturally acceptable
and may have contributed to HCV (Medhat et al., 2002; Yahia, 2011). Our study results
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revealed an increased odds of association between history of injection sharing and HCV
infection, with an unadjusted OR of 1.51 (1.07- 2.15). Regardless of the purpose of
receiving injections; those who had shared the syringe or needle had a higher risk for
HCV. Among all clinical variables, having had an injection for schistosomiasis remained
statistically significant in multivariate analysis. This finding is consistent with the vast
amount of literature supporting the relationship(Frank et al., 2000; Strickland, 2006).
Most notably, in addition to history of injection for schistosomiasis, having had FGM
remained statistically significant in multivariate analysis, even after adjusting for age and
schistosomiasis.
5b. Limitations
There are some limitations to the study. Although DHS uses a standardized
questionnaire and is designed to be a robust survey across countries, there are
opportunities for self-report bias with any secondary data. Secondly, a vast majority of
women included in this study had FGM, which may have strengthened the magnitude of
the relationship between FGM and HCV infections.
5c. Recommendations
Future studies’ analyzing the relationship between FGM and HCV among women
is warranted. Specifically, new studies need to employ recent data from EDHS 2012. A
more robust model would be to compare equal proportions of women who had FGM with
those who did not have FGM. Studies can also employ subjects from other countries to
compare similar relationships. Additionally, future studies need to consider preconceived
notions and beliefs and employ methods to quantify the association with HCV infections.
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Our study results reveal that many of the women would prefer for this practice to be
continued and that it is required by religious precepts. Among study subjects, more than
50% of women provided affirmative answers to religious precepts and FGM can
continue. In light of these results; it is necessary to consider that women may obtain FGM
through lay providers such as traditional midwives, barbers, and gypsies and put
themselves at risk for HCV infection.
5d. Strengths of the study
Despite limitations, this study has some notable strength. DHS employs a
nationally representative sample, and therefore the results of the study can be applicable
to the Egyptian women. Our study also included several variables that have not been
analyzed by previous studies; such as beliefs regarding FGM, and its association with
HCV infections.
5e. Conclusion
Prevention efforts need to be designed based on specific characteristics such as
women with less education and rural neighborhoods. Similarly, prevention efforts need to
be implemented with cultural sensitivity; educating religious leaders about the harmful
effects of FGM may provide an efficient means of bringing the practice to an end. The
Ministry of Health Program in Egypt institutes two programs for HCV; the first program
aims at providing treatment for those already infected with HCV(Yahia, 2011). The
second program facilitates prevention efforts. Re-directing funds towards prevention
programs, in addition to ongoing treatment of infected individuals is the most effective
means of reducing the burden of HCV in Egypt. The results of this study help provide
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useful insights to public health professionals to design and implement programs that are
efficient in preventing HCV transmission in Egypt.
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